NCT02881177View on ClinicalTrials.gov

Oxytocin HIV Meth Study

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Amphetamine Use Disorders
Interventions
DRUG

Oxytocin

40 IU

DRUG

Placebo

40 IU

Trial Locations (1)

94102

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02881177 - Oxytocin HIV Meth Study | Biotech Hunter | Biotech Hunter